Histone Deacetylase 7 Promotes PML Sumoylation and Is Essential for PML Nuclear Body Formation

REFERENCES

• Ayaydin, F., and M. Dasso. 2004. Distinct in vivo dynamics of vertebrate SUMO paralogues. Mol. Biol. Cell 15:5208–5218.
   PubMed Web of Science ®Google Scholar
• Bernardi, R., and P. P. Pandolfi. 2007. Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies. Nat. Rev. Mol. Cell Biol. 8:1006–1016.
   PubMed Web of Science ®Google Scholar
• Bernardi, R., P. P. Scaglioni, S. Bergmann, H. F. Horn, K. H. Vousden, and P. P. Pandolfi. 2004. PML regulates p53 stability by sequestering Mdm2 to the nucleolus. Nat. Cell Biol. 6:665–672.
   PubMed Web of Science ®Google Scholar
• Carbone, R., M. Pearson, S. Minucci, and P. G. Pelicci. 2002. PML NBs associate with the hMre11 complex and p53 at sites of irradiation induced DNA damage. Oncogene 21:1633–1640.
   PubMed Web of Science ®Google Scholar
• Chang, S., S. Bezprozvannaya, S. Li, and E. N. Olson. 2005. An expression screen reveals modulators of class II histone deacetylase phosphorylation. Proc. Natl. Acad. Sci. USA 102:8120–8125.
   PubMed Web of Science ®Google Scholar
• Chen, L. Y., and J. D. Chen. 2003. Daxx silencing sensitizes cells to multiple apoptotic pathways. Mol. Cell. Biol. 23:7108–7121.
   PubMed Web of Science ®Google Scholar
• Dellaire, G., and D. P. Bazett-Jones. 2004. PML nuclear bodies: dynamic sensors of DNA damage and cellular stress. Bioessays 26:963–977.
   PubMed Web of Science ®Google Scholar
• Dellaire, G., R. W. Ching, K. Ahmed, F. Jalali, K. C. Tse, R. G. Bristow, and D. P. Bazett-Jones. 2006. Promyelocytic leukemia nuclear bodies behave as DNA damage sensors whose response to DNA double-strand breaks is regulated by NBS1 and the kinases ATM, Chk2, and ATR. J. Cell Biol. 175:55–66.
   PubMed Web of Science ®Google Scholar
• Everett, R. D., and M. K. Chelbi-Alix. 2007. PML and PML nuclear bodies: implications in antiviral defence. Biochimie 89:819–830.
   PubMed Web of Science ®Google Scholar
• Fischer, D. D., R. Cai, U. Bhatia, F. A. Asselbergs, C. Song, R. Terry, N. Trogani, R. Widmer, P. Atadja, and D. Cohen. 2002. Isolation and characterization of a novel class II histone deacetylase, HDAC10. J. Biol. Chem. 277:6656–6666.
   PubMed Web of Science ®Google Scholar
• Fischle, W., S. Emiliani, M. J. Hendzel, T. Nagase, N. Nomura, W. Voelter, and E. Verdin. 1999. A new family of human histone deacetylases related to Saccharomyces cerevisiae HDA1p. J. Biol. Chem. 274:11713–11720.
   PubMed Web of Science ®Google Scholar
• Fu, C., K. Ahmed, H. Ding, X. Ding, J. Lan, Z. Yang, Y. Miao, Y. Zhu, Y. Shi, J. Zhu, H. Huang, and X. Yao. 2005. Stabilization of PML nuclear localization by conjugation and oligomerization of SUMO-3. Oncogene 24:5401–5413.
   PubMed Web of Science ®Google Scholar
• Gao, C., X. Cheng, M. Lam, Y. Liu, Q. Liu, K. S. Chang, and H. Y. Kao. 2008. Signal-dependent regulation of transcription by histone deacetylase 7 (HDAC7) involves recruitment to promyelocytic leukemia protein nuclear bodies. Mol. Biol. Cell 19:3020–3027.
   PubMedGoogle Scholar
• Gao, C., X. Li, M. Lam, Y. Liu, S. Chakraborty, and H. Y. Kao. 2006. CRM1 mediates nuclear export of HDAC7 independently of HDAC7 phosphorylation and association with 14-3-3s. FEBS Lett. 580:5096–5104.
   PubMedGoogle Scholar
• Ghisletti, S., W. Huang, S. Ogawa, G. Pascual, M. E. Lin, T. M. Willson, M. G. Rosenfeld, and C. K. Glass. 2007. Parallel SUMOylation-dependent pathways mediate gene- and signal-specific transrepression by LXRs and PPARγ. Mol. Cell 25:57–70.
   PubMed Web of Science ®Google Scholar
• Gregoire, S., and X. J. Yang. 2005. Association with class IIa histone deacetylases upregulates the sumoylation of MEF2 transcription factors. Mol. Cell. Biol. 25:2273–2287.
   PubMed Web of Science ®Google Scholar
• Grozinger, C. M., C. A. Hassig, and S. L. Schreiber. 1999. Three proteins define a class of human histone deacetylases related to yeast Hda1p. Proc. Natl. Acad. Sci. USA 96:4868–4873.
   PubMed Web of Science ®Google Scholar
• Guardiola, A. R., and T. P. Yao. 2002. Molecular cloning and characterization of a novel histone deacetylase HDAC10. J. Biol. Chem. 277:3350–3356.
   PubMed Web of Science ®Google Scholar
• Gurrieri, C., P. Capodieci, R. Bernardi, P. P. Scaglioni, K. Nafa, L. J. Rush, D. A. Verbel, C. Cordon-Cardo, and P. P. Pandolfi. 2004. Loss of the tumor suppressor PML in human cancers of multiple histologic origins. J. Natl. Cancer Inst. 96:269–279.
   PubMedGoogle Scholar
• Ishov, A. M., A. G. Sotnikov, D. Negorev, O. V. Vladimirova, N. Neff, T. Kamitani, E. T. Yeh, J. F. Strauss III, and G. G. Maul. 1999. PML is critical for ND10 formation and recruits the PML-interacting protein Daxx to this nuclear structure when modified by SUMO-1. J. Cell Biol. 147:221–234.
   PubMed Web of Science ®Google Scholar
• Jackson, P. K. 2001. A new RING for SUMO: wrestling transcriptional responses into nuclear bodies with PIAS family E3 SUMO ligases. Genes Dev. 15:3053–3058.
   PubMedGoogle Scholar
• Johnson, E. S. 2004. Protein modification by SUMO. Annu. Rev. Biochem. 73:355–382.
   PubMed Web of Science ®Google Scholar
• Kagey, M. H., T. A. Melhuish, S. E. Powers, and D. Wotton. 2005. Multiple activities contribute to Pc2 E3 function. EMBO J. 24:108–119.
   PubMedGoogle Scholar
• Kamitani, T., K. Kito, H. P. Nguyen, H. Wada, T. Fukuda-Kamitani, and E. T. Yeh. 1998. Identification of three major sentrinization sites in PML. J. Biol. Chem. 273:26675–26682.
   PubMedGoogle Scholar
• Kao, H. Y., M. Downes, P. Ordentlich, and R. M. Evans. 2000. Isolation of a novel histone deacetylase reveals that class I and class II deacetylases promote SMRT-mediated repression. Genes Dev. 14:55–66.
   PubMed Web of Science ®Google Scholar
• Kao, H. Y., C. H. Lee, A. Komarov, C. C. Han, and R. M. Evans. 2002. Isolation and characterization of mammalian HDAC10, a novel histone deacetylase. J. Biol. Chem. 277:187–193.
   PubMed Web of Science ®Google Scholar
• Kao, H. Y., A. Verdel, C. C. Tsai, C. Simon, H. Juguilon, and S. Khochbin. 2001. Mechanism for nucleocytoplasmic shuttling of histone deacetylase 7. J. Biol. Chem. 276:47496–47507.
   PubMed Web of Science ®Google Scholar
• Lallemand-Breitenbach, V., M. Jeanne, S. Benhenda, R. Nasr, M. Lei, L. Peres, J. Zhou, J. Zhu, B. Raught, and H. de The. 2008. Arsenic degrades PML or PML-RARα through a SUMO-triggered RNF4/ubiquitin-mediated pathway. Nat. Cell Biol. 10:547–555.
   PubMed Web of Science ®Google Scholar
• Lallemand-Breitenbach, V., J. Zhu, F. Puvion, M. Koken, N. Honore, A. Doubeikovsky, E. Duprez, P. P. Pandolfi, E. Puvion, P. Freemont, and H. de The. 2001. Role of promyelocytic leukemia (PML) sumolation in nuclear body formation, 11S proteasome recruitment, and As2O3-induced PML or PML/retinoic acid receptor alpha degradation. J. Exp. Med. 193:1361–1371.
   PubMed Web of Science ®Google Scholar
• Li, H., C. Leo, J. Zhu, X. Wu, J. O'Neil, E. J. Park, and J. D. Chen. 2000. Sequestration and inhibition of Daxx-mediated transcriptional repression by PML. Mol. Cell. Biol. 20:1784–1796.
   PubMed Web of Science ®Google Scholar
• Lin, D. Y., H. I. Fang, A. H. Ma, Y. S. Huang, Y. S. Pu, G. Jenster, H. J. Kung, and H. M. Shih. 2004. Negative modulation of androgen receptor transcriptional activity by Daxx. Mol. Cell. Biol. 24:10529–10541.
   PubMedGoogle Scholar
• Lin, D. Y., Y. S. Huang, J. C. Jeng, H. Y. Kuo, C. C. Chang, T. T. Chao, C. C. Ho, Y. C. Chen, T. P. Lin, H. I. Fang, C. C. Hung, C. S. Suen, M. J. Hwang, K. S. Chang, G. G. Maul, and H. M. Shih. 2006. Role of SUMO-interacting motif in Daxx SUMO modification, subnuclear localization, and repression of sumoylated transcription factors. Mol. Cell 24:341–354.
   PubMed Web of Science ®Google Scholar
• Meinecke, I., A. Cinski, A. Baier, M. A. Peters, B. Dankbar, A. Wille, A. Drynda, H. Mendoza, R. E. Gay, R. T. Hay, B. Ink, S. Gay, and T. Pap. 2007. Modification of nuclear PML protein by SUMO-1 regulates Fas-induced apoptosis in rheumatoid arthritis synovial fibroblasts. Proc. Natl. Acad. Sci. USA 104:5073–5078.
   PubMedGoogle Scholar
• Nisole, S., J. P. Stoye, and A. Saib. 2005. TRIM family proteins: retroviral restriction and antiviral defence. Nat. Rev. Microbiol. 3:799–808.
   PubMed Web of Science ®Google Scholar
• Pichler, A., P. Knipscheer, H. Saitoh, T. K. Sixma, and F. Melchior. 2004. The RanBP2 SUMO E3 ligase is neither HECT- nor RING-type. Nat. Struct. Mol. Biol. 11:984–991.
   PubMedGoogle Scholar
• Reineke, E. L., M. Lam, Q. Liu, Y. Liu, K. J. Stanya, K. S. Chang, A. R. Means, and H. Y. Kao. 2008. Degradation of the tumor suppressor PML by Pin1 contributes to the cancer phenotype of breast cancer MDA-MB-231 cells. Mol. Cell. Biol. 28:997–1006.
   PubMedGoogle Scholar
• Saitoh, N., T. Aoto, S. Tei, E. Niki, Y. Nakatsu, and M. Nakao. 2006. Nuclear organelles in the interchromosomal region. Tanpakushitsu Kakusan Koso. 51:1957-1963. (In Japanese.)
   PubMedGoogle Scholar
• Schmidt, D., and S. Muller. 2003. PIAS/SUMO: new partners in transcriptional regulation. Cell. Mol. Life Sci. 60:2561–2574.
   PubMed Web of Science ®Google Scholar
• Schuetz, A., J. Min, A. Allali-Hassani, M. Schapira, M. Shuen, P. Loppnau, R. Mazitschek, N. P. Kwiatkowski, T. A. Lewis, R. L. Maglathin, T. H. McLean, A. Bochkarev, A. N. Plotnikov, M. Vedadi, and C. H. Arrowsmith. 2008. Human HDAC7 harbors a class IIa histone deacetylase-specific zinc binding motif and cryptic deacetylase activity. J. Biol. Chem. 283:11355–11363.
   PubMed Web of Science ®Google Scholar
• Shen, T. H., H. K. Lin, P. P. Scaglioni, T. M. Yung, and P. P. Pandolfi. 2006. The mechanisms of PML-nuclear body formation. Mol. Cell 24:331–339.
   PubMed Web of Science ®Google Scholar
• Stankovic-Valentin, N., S. Deltour, J. Seeler, S. Pinte, G. Vergoten, C. Guerardel, A. Dejean, and D. Leprince. 2007. An acetylation/deacetylation-SUMOylation switch through a phylogenetically conserved ψKXEP motif in the tumor suppressor HIC1 regulates transcriptional repression activity. Mol. Cell. Biol. 27:2661–2675.
   PubMedGoogle Scholar
• Tatham, M. H., M. C. Geoffroy, L. Shen, A. Plechanovova, N. Hattersley, E. G. Jaffray, J. J. Palvimo, and R. T. Hay. 2008. RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation. Nat. Cell Biol. 10:538–546.
   PubMed Web of Science ®Google Scholar
• Tong, J. J., J. Liu, N. R. Bertos, and X. J. Yang. 2002. Identification of HDAC10, a novel class II human histone deacetylase containing a leucine-rich domain. Nucleic Acids Res. 30:1114–1123.
   PubMedGoogle Scholar
• Verdel, A., and S. Khochbin. 1999. Identification of a new family of higher eukaryotic histone deacetylases. Coordinate expression of differentiation-dependent chromatin modifiers. J. Biol. Chem. 274:2440–2445.
   PubMedGoogle Scholar
• Xu, Z. X., R. X. Zhao, T. Ding, T. T. Tran, W. Zhang, P. P. Pandolfi, and K. S. Chang. 2004. Promyelocytic leukemia protein 4 induces apoptosis by inhibition of survivin expression. J. Biol. Chem. 279:1838–1844.
   PubMed Web of Science ®Google Scholar
• Yang, X. J., and E. Seto. 2008. The Rpd3/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and men. Nat. Rev. Mol. Cell Biol. 9:206–218.
   PubMed Web of Science ®Google Scholar
• Zhao, X., T. Sternsdorf, T. A. Bolger, R. M. Evans, and T. P. Yao. 2005. Regulation of MEF2 by histone deacetylase 4- and SIRT1 deacetylase-mediated lysine modifications. Mol. Cell. Biol. 25:8456–8464.
   PubMed Web of Science ®Google Scholar
• Zheng, G., and Y. C. Yang. 2005. Sumoylation and acetylation play opposite roles in the transactivation of PLAG1 and PLAGL2. J. Biol. Chem. 280:40773–40781.
   PubMedGoogle Scholar
• Zhong, S., S. Muller, S. Ronchetti, P. S. Freemont, A. Dejean, and P. P. Pandolfi. 2000. Role of SUMO-1-modified PML in nuclear body formation. Blood 95:2748–2752.
   PubMed Web of Science ®Google Scholar
• Zhou, X., P. A. Marks, R. A. Rifkind, and V. M. Richon. 2001. Cloning and characterization of a histone deacetylase, HDAC9. Proc. Natl. Acad. Sci. USA 98:10572–10577.
   PubMed Web of Science ®Google Scholar